Last reviewed · How we verify

ethinyl estradiol and levonorgestrel; exenatide

AstraZeneca · Phase 1 active Small molecule

ethinyl estradiol and levonorgestrel; exenatide is a Small molecule drug developed by AstraZeneca. It is currently in Phase 1 development. Also known as: Byetta, AC2993.

At a glance

Generic nameethinyl estradiol and levonorgestrel; exenatide
Also known asByetta, AC2993
SponsorAstraZeneca
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ethinyl estradiol and levonorgestrel; exenatide

What is ethinyl estradiol and levonorgestrel; exenatide?

ethinyl estradiol and levonorgestrel; exenatide is a Small molecule drug developed by AstraZeneca.

Who makes ethinyl estradiol and levonorgestrel; exenatide?

ethinyl estradiol and levonorgestrel; exenatide is developed by AstraZeneca (see full AstraZeneca pipeline at /company/astrazeneca).

Is ethinyl estradiol and levonorgestrel; exenatide also known as anything else?

ethinyl estradiol and levonorgestrel; exenatide is also known as Byetta, AC2993.

What development phase is ethinyl estradiol and levonorgestrel; exenatide in?

ethinyl estradiol and levonorgestrel; exenatide is in Phase 1.

Related